Trends in Metabolic Bariatric Surgery Utilization in the Era of GLP-1s, 2022-2024

JAMA Surgery 2026 Open access

Read full text
Authors: Robert Calzaretta, Stephen Fink, Kabir Kothari, Thomas C. Tsai
DOI: 10.1001/jamasurg.2026.1343
Cited by: 1
References: 3

Abstract

This study examines trends in metabolic bariatric surgery utilization in the era of glucagon-like peptide-1 receptor agonists.

Fields of Study & Subjects

Bariatric Surgery and Outcomes Diabetes Treatment and Management Hyperglycemia and glycemic control in critically ill and hospitalized patients

Publication details

Journal / source
JAMA Surgery
Publisher
American Medical Association (AMA)
Volume
161
Issue
7
Pages
746–746
Publication date
13 May 2026
Language
EN